Optimizing RAASi Therapy: The Role of Personalized Medicine - a podcast by ReachMD

CME credits: 0.25

Valid until: 31-01-2023

Claim your CME credit at https://reachmd.com/programs/cme/optimizing-raasi-therapy-the-role-of-personalized-medicine/13124/

Hyperkalemia is common in chronic heart failure and is associated with an increased risk of hospitalization and death. The incidence is further elevated in those with chronic kidney disease, and the presence of hyperkalemia can often lead to clinical delay and suboptimal dosing of RAAS inhibitors in these patients.

Join the discussion as Drs. George Bakris and Giuseppe Rosano examine the management of hyperkalemia in patients with HF and provide individualized approaches for optimizing RAASi therapy. Collaboration between nephrologists and cardiologists is key, and these experts make sure to stress the strong connection between the heart and kidneys when managing these patients.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD